Kazantseva, A.,
Enikeeva, R.,
Takhirova, Z.,
Davydova, Y.,
Mustafin, R.,
Malykh, S.,
Karunas, A.,
Kanapin, A.,
Khusnutdinova, E. (2023) -related effects of SARS-CoV-2 infection on the presence of accompanying and long-
term post-COVID-19 neurological
For two years, the COVID-19 pandemic has become one of the most dif-ficult in
terms of medical
Chu, Shuk Han,
Zhao, Xu,
Komber, Ahmad,
Cheyne, Joshua,
Wu, Simiao,
Cowey, Eileen,
Kutlubaev, Mansur,
Mead, Gillian (2023) completed trials, 6 unpublished completed trials, and 6 ongoing trials. Pharmacological
treatments were
Shnayder, Natalia A.,
Grechkina, Violetta V.,
Trefilova, Vera V.,
Efremov, Ilya S.,
Dontceva, Evgenia A.,
Narodova, Ekaterina A.,
Petrova, Marina M.,
Soloveva, Irina A.,
Tepnadze, Liia E.,
Reznichenko, Polina A.,
Al-Zamil, Mustafa,
Altynbekova, Gulnara I.,
Strelnik, Anna I.,
Nasyrova, Regina F. (2023) that are widely used in neurology and psychiatry. The long-
term use of VPA increases the risk of developing
of Hydrangea arborescens; coumarins in
terms of umbelliferone are in the roots (0.41 ± 0.007%); and the content